Postcolorectal Endoscopic Mucosal Resection Follow-up Is Essential
Douglas K. Rex, MD, MASGE, reviewing El Rahyel A, et al. Gastroenterology 2020 Oct 29.
There is a well-known risk of adenoma recurrence after piecemeal endoscopic mucosal resection (EMR).
In a single-center study of 2411 nonpedunculated lesions ≥20 mm in size, with complete EMR and no submucosal invasion by pathologic assessment, the overall recurrence rates at first, second, and third follow-ups were 15.2%, 3.4%, and 1.1%, respectively. Of 155 first overt recurrences treated endoscopically and followed, the rate of residual polyp at the next follow-up was 14.8%. Of 17 lesions that recurred overtly twice and were followed, 94.1% were successfully eradicated by the second treatment. Three patients developed adenocarcinoma at the EMR site during follow-up. Although the study was performed at a referral center, overall, 27.5% of patients did not return for the first follow-up, 40.8% did not return for the second follow-up, and 55.9% did not return for the third follow-up.
Note to readers: At the time we reviewed this paper, its publisher noted that it was not in final form and that subsequent changes might be made.
CITATION(S)
El Rahyel A, Abdullah N, Love E, Vemulapal KC, Rex DK. Recurrence after endoscopic mucosal resection: early and late incidence, treatment outcomes, and outcomes in non-overt (histologic-only) recurrence. Gastroenterology 2020 Oct 29. (Epub ahead of print) (https://doi.org/10.1053/j.gastro.2020.10.039)